EnhancerAtlas 2.0: an updated resource with typical enhancer annotation in 600 tissue/cell types across nine species
EnhancerAtlas 2.0
TagContent
EnhancerAtlas ID
HS110-00299 
Organism
Homo sapiens 
Tissue/cell
KATO3 
Coordinate
chr1:201991040-201992880 
TF binding sites/motifs
Number: 5             
TFJASPAR IDCoordinateMotif SequenceStrand-Log10(p-value)
Nr2f6(var.2)MA0728.1chr1:201991522-201991537GAGGTCAGAAGTTCA+6.38
TBX21MA0690.1chr1:201992769-201992779AAGGTGTGAA+6.02
TBX2MA0688.1chr1:201992769-201992780AAGGTGTGAAT+6.02
ZNF263MA0528.1chr1:201992213-201992234CGCTCCTCCTCCTCCTCCTTC-8.44
ZNF263MA0528.1chr1:201992216-201992237TCCTCCTCCTCCTCCTTCTTC-8.69
Number of super-enhancer constituents: 28             
IDCoordinateTissue/cell
SE_23058chr1:201990827-201991297Colon_Crypt_1
SE_23058chr1:201991682-201993038Colon_Crypt_1
SE_23723chr1:201990919-201991273Colon_Crypt_2
SE_23723chr1:201991793-201992845Colon_Crypt_2
SE_24689chr1:201990748-201991252Colon_Crypt_3
SE_24689chr1:201991746-201993176Colon_Crypt_3
SE_25977chr1:201991449-201992586Duodenum_Smooth_Muscle
SE_26730chr1:201991584-201993071Esophagus
SE_27624chr1:201991445-201993333Fetal_Intestine
SE_28545chr1:201991443-201993383Fetal_Intestine_Large
SE_31432chr1:201991670-201993044Gastric
SE_33417chr1:201991427-201994657H2171
SE_33792chr1:201990657-201991281HCC1954
SE_33792chr1:201991430-201993180HCC1954
SE_34304chr1:201991505-201993289HCT-116
SE_34741chr1:201990653-201993194HeLa
SE_41626chr1:201991969-201992570LNCaP
SE_43434chr1:201990679-201991267MCF-7
SE_43434chr1:201991624-201993665MCF-7
SE_50066chr1:201991627-201993065Sigmoid_Colon
SE_52354chr1:201991432-201993050Small_Intestine
SE_56834chr1:201991684-201992300VACO_400
SE_56834chr1:201992323-201993032VACO_400
SE_57376chr1:201991848-201992311VACO_503
SE_57945chr1:201991851-201992344VACO_9m
SE_57945chr1:201992487-201992749VACO_9m
SE_65333chr1:201992691-201993394Pancreatic_islets
SE_67013chr1:201991427-201994657H2171
Diseases: AD,Huntington,Obesity,Parkinson,Prostate cancer,Schizophrenia and Sleep disorder
Number of disease enhancers: 1             
ChromosomeStartEnd
chr1201991192201991253
Enhancer Sequence
ACATCATTCA TTCTCTCTGT GTTCATTAAC TGTCTGCTGT GTGCATGGCT CCATGCTGTG 60
TGCAGAAGAC CCAGTAGGGA AGAGGTCACC CAGGGGGAGT AGGAAGCCTA GGCTATGGCC 120
TGGCACGGTG GCTTATACCT GTAATCCCAG CACTTTGGGA GGCTGAGGCG GGTAAATCAC 180
CTGAGGGCAG GAATTTGAGA CCAGCCTGGC CAACATGGCG AAACCCCATC TCTAGTAAAA 240
ATACAAAAAT TAGCCGGGCG TGGTGGCGGG TGCCTGTAAT CCCAGCTACT TTGGAGGCTG 300
AGGCAGGAGA ATCACTTGAA CCCGAGAGGA GAAGGTTGCG GTGAGCCGAG ATCACACCAC 360
TGCACTCCAG CCAGGCGACA GAGTGAGATT CCATCTCAAA AAAAAAAAAA AAAAAAAATT 420
CCTGGTGCAG TGGCTCAGGC TTGTAATCCC AGCACTTTGG GAGGCTGAGG CGGATGAATC 480
ATGAGGTCAG AAGTTCAAAA CCAGCCTGGC CAAGATGGTG AAACCGCGTC TCTACTAAAA 540
ATACAAAAAA ATTAGCCGGG TATGGTGGCA GCTGCCTGTA ATACCAGCTA CTCGGAAGGC 600
TGAGGCAGAT AATTGCTTGA ACCTGGGAGG CAGAGGTTGC AGTGAGCTGA GATCATGCCA 660
CTGCACTCCA GACTGGGTGG CAGAGTGAGA CTCCATCTCA AAAAAAAAGA AAAGAAAAGA 720
AAGAAAGCCT AGGCTAGAGC CTAGGAAATT CCAAAGACAT CTATATAAAC CTCTCAACAA 780
GGTAGAGGAT AAGTGCCTCA TTTCACAGAT GAGCAAACTG AGGCTTCAGA GAGGTTAAGA 840
AAAGCTTAAG CTCTCAGAGA TAGTAGTAAG TTTAGGAAAC CGGAGCTTGA ACCCTGCCTT 900
CTTTCTTCAA TTCCACAGCT GACTCTGCTT TGAGAGGTGC TGAGCAACAC AAATGTCTCC 960
GCTGTATGGG TGCCTAAAAC CCCACCATTA GATGTGCAGT TTGAGGAATG CCCTATGGAT 1020
ATACAAACAT GCCTGGGGTG GAGGGTGGAT TCAATGAGCA TTGCTTTCCA GGGACCCTTG 1080
GATCCTGCAG GGTGGATGGA AAGTGAGTTT TCAGTTCTTC AGAACCTCAC AGTGGCCAAC 1140
CCTTGGGAGC ATTGCCCTCT CATTCTTATC CTACGCTCCT CCTCCTCCTC CTTCTTCTGC 1200
TACGTGCAGG GCTGGGCTGG GGCACCAGCA GCAGCAATTA GCCCAGCTCA GCCGCCCGTT 1260
ACTGGAACCT GCATGTCAAC TCTGGAGCTG ATCCAAGAAA CCACACCCAG TGTCCTGCAT 1320
GACTCAACCT CACCTGCCCC CTCCACACCT GCCAGCCTCA GTGACCCAGG CCATAGTGCC 1380
CAGGGGAAAG TCCCAGCATC CTTTGGTCAA TCCTCATCTA CTCCATGTGT TTGTAAGGCC 1440
AGCTGGGATT TAGAGTCTTT GTATCACAGG CTTGATTCCG GGCTGATTTC TAGCCAGGAG 1500
AGAATGCTCC AGGCGGAGCA AATGCTGGGG TTTGGAAAAC TAGACTCTCC ATGGCAAATG 1560
CAGACAGATG GACCTCCTCT TCACTATCAT TGCTTGAAAC ACGAACAGCT TAAGGCCATG 1620
GGAGATATTA CTTTTCATAT GTCAAATTGG CAAAGAATTA AAGAATGCCC CTGATGTCTA 1680
GAGCTGGTGA GGATGTGAAG AAACTCAAAC TTGACAAAAA CCACTCGTCA AGGTGTGAAT 1740
TGAGAGACAC TTTTTTTTCG AGATGGAGTC TTGCGCTGTC GCCCACGCTG GAGTGTAGTG 1800
GTGCAATCTC AGCTCACTGC AACCTCTGCC TTCCAGATTC 1840